| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.6M | +20.8% |
| Cost of Revenue | $24.2M | +39.4% |
| Gross Profit | $3.4M | -37.9% |
| R&D Expense | $875K | -16.7% |
| SG&A Expense | $9.1M | -5.8% |
| Operating Income | -$6.6M | -25.7% |
| Pre-tax Income | -$6.4M | -33.7% |
| Income Tax | $74K | +105.2% |
| Net Income | -$6.0M | -118.8% |
| EPS (Basic) | -$0.54 | -118.2% |
| EPS (Diluted) | -$0.54 | -118.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.1M | -60.0% |
| Inventory | $6.3M | +4.1% |
| Current Assets | $25.5M | -54.9% |
| Total Assets | $35.5M | -46.2% |
| Current Liabilities | $4.9M | -83.7% |
| Total Liabilities | $6.1M | -79.9% |
| Stockholders' Equity | $29.3M | -17.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | +6.3% |
| Capital Expenditures | $2.7M | -28.8% |
| Investing Cash Flow | -$3.9M | -110.0% |
| Financing Cash Flow | -$16.9M | -415.3% |
| Free Cash Flow | -$8.5M | +14.8% |